Chun-Wan received her Bachelor's degree in Chemistry from National Taiwan University. She then pursued her Ph.D. in Chemistry at the Georgia Institute of Technology. Following her Ph.D., she was awarded an ORISE fellowship and conducted postdoctoral research at the Massachusetts Institute of Technology. In 2015, Chun-Wan began her industrial career at Merck Research Laboratory from 2015-2018. She is currently a Senior Principal Scientist in the Synthetic Molecule Pharmaceutical Sciences at Genentech. She is the CMC lead for parenteral formulation development. Her research interests include drug delivery for exotic modalities such as oligonucleotides, peptides, and mRNAs to support undruggable targets. Chun-Wan has published 40 peer-reviewed papers and holds four patents.
